おかえりなさい
アカウント登録
siteでログインする
siteで登録する
受信トレイを確認する
Perlegen Sciences
About
Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.
- 51 - 100
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $74M
- Industries
- Biotechnology,Genetics,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2000
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Perlegen Sciences engages in the discovery and commercialization of genetic variations that provide physicians with information to improve the clinical decision-making process and patient treatment outcomes. Its products include MammaPLUS, a breast cancer risk stratifier and a panel of common genetic variants that stratifies individual genetic and background/clinical risk for those at moderately elevated risk for non-familial breast cancer, as well as impacts the risk for developing invasive breast cancer; and Genotype Browser Website that provides a way to access and view the results of a study of genetic variation in various diverse human populations. Perlegen Sciences, Inc. was founded in 2000 and is based in Mountain View, California.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2006 | Series D | $50M | 5 | — | — | Detail |
| Feb 28, 2005 | Series D | $74M | 5 | — | — | Detail |
| Jan 28, 2003 | Series C | $30M | 2 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
BSI SA
|
— | Series D |
|
|
— | Series D |
SB Life Science
|
— | Series D |
|
|
— | Series D |
Biofrontier Partners
|
— | Series D |
